PTC Therapeutics
$57.879876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$57.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.87 (+1.53%) Today
$0.00 (0.00%) As of 10:03 PM UTC after-hours
Why Robinhood?
You can buy or sell PTCT and other stocks, options, and ETFs commission-free!
About PTCT
PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ. The listed name for PTCT is PTC Therapeutics, Inc. Common Stock.
CEO
Stuart Walter Peltz
Employees
761
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
4.05B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
603.47K
High Today
$58.71
Low Today
$55.74
Open Price
$56.10
Volume
918.17K
52 Week High
$70.82
52 Week Low
$30.79
Analyst Ratings
54%
of 13 ratings
Buy
54%
Hold
38%
Sell
8%
PTCT Earnings
-$2.62
-$1.76
-$0.90
-$0.04
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.94 per share
Actual
-$1.08 per share